ArticleFrontiers in allergy2022

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.

Elizabeth García-Gómez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.